Hong Qin

3PUBLICATIONS
15CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|May 27, 2020
Antitumor efficacy of BAFF-R targeting CAR T cells manufactured under clinic-ready conditions.

Zhenyuan Dong, Wesley A Cheng, D Lynne Smith

|Sep 27, 2019
CAR T cells targeting BAFF-R can overcome CD19 antigen loss in B cell malignancies.

Hong Qin, Zhenyuan Dong, Xiuli Wang

Pageof 1